Chemical, often household, breathed in to cause intoxication
Medical condition Inhalants are a broad range of household and industrial chemicals whose volatile vapors or pressurized gases can be concentrated and breathed in via the nose or mouth to produce intoxication, in a manner not intended by the manufacturer. They are inhaled at room temperature through volatilization (in the case of gasoline or acetone) or from a pressurized container (e.g., nitrous oxide or butane), and do not include drugs that are sniffed after burning or heating.
While a few inhalants are prescribed by medical professionals and used for medical purposes, as in the case of inhaled anesthetics and nitrous oxide (an anxiolytic and pain relief agent prescribed by dentists), this article focuses on inhalant use of household and industrial propellants, glues, fuels, and other products in a manner not intended by the manufacturer, to produce intoxication or other psychoactive effects. These products are used as recreational drugs for their intoxicating effect. According to a 1995 report by the National Institute on Drug Abuse, the most serious inhalant use occurs among homeless children and teenagers who "live on the streets completely without family ties." Inhalants are the only substance used more by younger teenagers than by older teenagers. Inhalant users inhale vapor or aerosol propellant gases using plastic bags held over the mouth or by breathing from a solvent-soaked rag or an open container. The practices are known colloquially as "sniffing", "huffing" or "bagging".
The effects of inhalants range from an alcohol-like intoxication and intense euphoria to vivid hallucinations, depending on the substance and the dose. Some inhalant users are injured due to the harmful effects of the solvents or gases or due to other chemicals used in the products that they are inhaling. As with any recreational drug, users can be injured due to dangerous behavior while they are intoxicated, such as driving under the influence. In some cases, users have died from hypoxia (lack of oxygen), pneumonia, heart failure, cardiac arrest, or aspiration of vomit. Brain damage is typically seen with chronic long-term use of solvents as opposed to short-term exposure.
While legal when used as intended, in England, Scotland, and Wales it is illegal to sell inhalants to persons likely to use them as an intoxicant. As of 2017, thirty-seven US states impose criminal penalties on some combination of sale, possession or recreational use of various inhalants. In 15 of these states, such laws apply only to persons under the age of 18.
Safety at a Glance
High Risk- General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual se...
- Toxicity: Table from the 2010 ISCD study ranking various drugs (legal and illegal) based on statements by drug-harm experts. Bu...
- Dangerous with: Acetylfentanyl, Buprenorphine, Codeine, Desomorphine (+15 more)
- Overdose risk: Overdose on Inhalants can range from unpleasant to life-threatening depending on the dose, route,...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Duration
No duration data available.
How It Feels
The experience arrives with savage immediacy — one breath and the world detonates. Within seconds a roaring pressure fills the skull, as though the inside of your head has been replaced by a turbine engine. Your visual field fractures into strobing, pulsing fragments, each one trailing afterimages that overlap and interfere with one another. Sound warps into a rhythmic, mechanical throbbing — wah-wah-wah — as though reality itself has been fed through a tremolo pedal set to maximum speed. Your body becomes a distant, vibrating mass; you can feel it somewhere below you, but the signals it sends are scrambled into pure sensation without location or meaning.
This is not a come-up in any conventional sense. The onset is the peak, arrived at with the violence of a trapdoor opening beneath your feet. For fifteen to thirty seconds, consciousness is overwhelmed by a rushing, tumbling dissociation that bears no resemblance to the structured experiences of ketamine or PCP analogues. There is no architecture here, no geometric space to explore — only a raw, undifferentiated blur of sensation, a sensory avalanche that the mind cannot organize into coherent experience. Dizziness is extreme and total; the concept of up and down becomes meaningless. Some describe a brief, intense euphoria — a surge of giddy, almost hysterical pleasure that arrives and departs in the span of a heartbeat.
As quickly as it arrived, it recedes. Within one to three minutes the rushing subsides, the strobing slows, and the room begins to reassemble itself around you, though for several minutes more it may feel unstable, as though viewed through heat shimmer. Your body returns to you in pieces — first your hands, then your weight, then the cold of the floor beneath you. A headache often follows immediately, pressing and dull, accompanied by a faint nausea and a metallic taste that clings to the back of the throat.
The aftermath is uniformly unpleasant: dizziness, fatigue, a thick-headed confusion that can persist for an hour or more. There is no afterglow, no residual warmth, no contemplative residue. The experience leaves behind only a vague sense of having been briefly and violently elsewhere, and the headache, which settles in with the stubborn permanence of an uninvited guest. The body feels used and slightly damaged, as though it has been shaken hard and put back down carelessly.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(7)
- Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
- Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Nystagmus— Rapid, involuntary oscillating movements of the eyes that cause vision to vibrate and blur, often ma...
- Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
- Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
Cognitive & Perceptual Effects
Visual(3)
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Visual strobing— A visual effect consisting of rapid, rhythmic flashes of light across the visual field, resembling a...
Cognitive(5)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Depersonalization— A detachment from one's own sense of self, body, or mental processes, as if observing oneself from o...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
Transpersonal(1)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
Pharmacology
Inhalants primarily acts as an antagonist at N-methyl-D-aspartate (NMDA) glutamate receptors, blocking the ion channel in a use-dependent manner. This NMDA receptor blockade disrupts normal glutamatergic neurotransmission, leading to the characteristic dissociative state involving detachment from sensory input, altered proprioception, and modified cognitive processing.
Additional pharmacological actions may include interactions with sigma receptors, dopamine transporters, opioid receptors (particularly kappa and mu subtypes), and voltage-gated sodium channels. The relative contribution of these secondary targets varies between dissociative compounds and influences the specific character of the experience.
At subanesthetic doses, NMDA blockade paradoxically increases glutamate release in certain brain regions through disinhibition of GABAergic interneurons. This downstream glutamate surge, particularly in the prefrontal cortex, may contribute to the psychotomimetic and dissociative effects.
Detection Methods
Standard Drug Panel Inclusion
Inhalants as a class are NOT included on standard 5-panel or 10-panel drug screens. The diverse chemical nature of inhalants, which include volatile solvents (toluene, xylene), gases (nitrous oxide, butane), aerosol propellants (fluorocarbons), and alkyl nitrites (amyl nitrite, isobutyl nitrite), means that no single immunoassay can screen for the entire class. Standard drug panels do not detect any inhalant substance. Specialized volatile substance testing must be specifically requested.
Urine Detection
Detection varies dramatically by substance. Toluene can be detected as its metabolite hippuric acid in urine for 2 to 3 days after exposure. Other solvents produce specific urinary metabolites: xylene yields methylhippuric acid, n-hexane produces 2,5-hexanedione, and trichloroethylene yields trichloroacetic acid. Nitrous oxide does not produce a detectable urinary metabolite. Alkyl nitrites are rapidly metabolized and are undetectable in urine by conventional methods. Urine testing for volatile substances requires specific metabolite-targeted GC-MS or LC-MS/MS methods.
Blood and Serum Detection
Many volatile inhalants can be detected in blood using headspace gas chromatography for 4 to 12 hours after exposure. The short detection windows reflect rapid pulmonary elimination. Blood samples must be collected in special containers (headspace vials with minimal dead space) and stored at cold temperatures to prevent analyte loss. Toluene blood concentrations above 0.5 mg/L indicate recent exposure.
Hair Follicle Detection
Hair testing has been developed for some solvent metabolites, particularly toluene, but is not routinely available. Most volatile substances do not incorporate into hair in detectable quantities.
Confirmatory Methods
Headspace GC-MS is the gold standard for volatile substance identification in biological specimens. The method involves heating the sample in a sealed vial and analyzing the vapor phase for volatile organic compounds. Multiple analytes can be screened simultaneously. Reference panels typically include common solvents, fluorocarbons, and fuel gases.
Reagent Testing
Reagent testing is not applicable to inhalant substances. The gaseous or highly volatile nature of these compounds precludes the use of standard colorimetric reagents. Identification of specific inhalant products relies on product labeling and analytical chemistry methods.
Interactions
| Substance | Status | Note |
|---|---|---|
| Acetylfentanyl | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Buprenorphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Codeine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Desomorphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Dextropropoxyphene | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Dihydrocodeine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Ethylmorphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Fentanyl | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Heroin | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Hydrocodone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Hydromorphone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Kratom | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Methadone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Morphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Naloxone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| O-Desmethyltramadol | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Oxycodone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Oxymorphone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Pethidine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| 1,4-Butanediol | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 2-Fluorodeschloroketamine | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 2M2B | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-Cl-PCP | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-HO-PCE | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 1,3-Butanediol | Low Risk & Synergy | Produces unique synergistic effects; often combined |
| 1B-LSD | Low Risk & Synergy | Produces unique synergistic effects; often combined |
| 1cP-AL-LAD | Low Risk & Synergy | Produces unique synergistic effects; often combined |
| 1cP-LSD | Low Risk & Synergy | Produces unique synergistic effects; often combined |
| 1cP-MiPLA | Low Risk & Synergy | Produces unique synergistic effects; often combined |
History
Inhalants belongs to the dissociative class of substances, a pharmacological category with roots in anesthesiology research. The first dissociative anesthetic, phencyclidine (PCP), was developed in the 1950s by Parke-Davis as a surgical anesthetic. While PCP was effective, its pronounced emergence phenomena (confusion, hallucinations, agitation upon waking) led researchers to develop alternatives with more manageable side effect profiles.
Ketamine, synthesized in 1962, became the most successful clinical dissociative anesthetic and remains in widespread medical use today. The discovery that sub-anesthetic doses of ketamine produce rapid antidepressant effects has driven renewed clinical interest in dissociative compounds.
Inhalants emerged within this broader landscape of dissociative pharmacology. Novel dissociative compounds continue to be developed by researchers and have appeared in the designer drug market, with varying degrees of resemblance to the established clinical agents.
Harm Reduction
General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual sensitivity varies enormously.
- Test your substances: Use reagent test kits to verify identity and check for dangerous adulterants. Consider using drug checking services where available.
- Research thoroughly: Understand expected dose ranges, duration, potential interactions, and contraindications before use.
- Never use alone: Have a trusted, sober person present, especially with new substances or higher doses.
- Set and setting: Your mindset and environment profoundly influence the experience. Choose a safe, comfortable environment and ensure you're in a stable psychological state.
Inhalants-Specific Harm Reduction
- Fall risk: Motor coordination is significantly impaired. Stay seated or lying down, especially at higher doses. Remove tripping hazards from your environment.
- Nausea management: Have an anti-emetic available and use on an empty or light stomach. If vomiting occurs while dissociated, ensure the person is in the recovery position to prevent aspiration.
- Combination danger: Combining with other depressants (alcohol, opioids, benzodiazepines) dramatically increases the risk of respiratory depression and loss of consciousness. This combination can be fatal.
- Bladder health: Chronic use of some dissociatives (particularly ketamine) can cause severe bladder damage (ulcerative cystitis). Limit frequency of use and stay well hydrated.
- Tolerance awareness: Dissociative tolerance develops quickly. Escalating doses to achieve the same effects significantly increases risk.
Toxicity & Safety
Table from the 2010 ISCD study ranking various drugs (legal and illegal) based on statements by drug-harm experts. Butane was found to be the 14th overall most dangerous drug. This section covers risks general risks for both medical and nonmedical inhalants. For specific risks with nonmedical inhalants, see Toxicity and harm potential for toxic inhalants
It is strongly recommended that one use harm reduction practices when using this class of substances.
Both medical and nonmedical inhalants should be avoided by:
Inhaling large quantities continuously with a strap-on mask connected to a gas canister. Because it will eventually cause oxygen deprivation. In some cases, users have died from a lack of oxygen, also known as hypoxia.
Inhaling compressed gas directly from a container. Because it can cause aerosol burn and frostbite.
Addiction potential
The chronic use of many inhalants can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.
Oxygen deprivation
The direct inhalation of any gas or solvent that is capable of displacing oxygen in the lungs (especially gases heavier than oxygen itself) carries the risk of hypoxia (oxygen deprivation) as a result of the very mechanism by which breathing is triggered.
Since reflexive breathing is prompted by elevated carbon dioxide levels rather than diminished blood oxygen levels, breathing a concentrated and inert solvent or gas (ex: tetrafluoromethane or nitrous oxide) that removes carbon dioxide from the blood without replacing it with oxygen will produce no outward signs of suffocation even when the brain is experiencing hypoxia.
Once full symptoms of hypoxia appear, it may be too late to breathe without assistance, especially if the gas is heavy enough to sink in and remain in the lungs for extended periods of time. Even completely inert gasses, such as argon, can have this effect if oxygen is largely excluded. This dangerous property of heavy gasses makes many inhalants inherently unsafe.
If one is inhaling an inhalant that is a pure compound, they will not be inhaling any oxygen. Severe oxygen deprivation can lead to unconsciousness and death. 'Huffing' from a bag that contains no fresh oxygen source is an especially risky practice in this respect. When inhaling gasses directly from a balloon or canister, it is imperative that one also intake an adequate amount of oxygen to prevent brain damage and cell death.
Addiction Potential
moderately addictive with a high potential for abuse
Overdose Information
Overdose on Inhalants can range from unpleasant to life-threatening depending on the dose, route, and whether other substances are involved.
Signs of overdose: Severe nystagmus, complete unresponsiveness, vomiting (aspiration risk while unconscious), severely depressed breathing, seizures, extremely elevated heart rate or blood pressure.
Critical dangers:
- Respiratory depression: Particularly when combined with other depressants
- Aspiration: Loss of protective reflexes combined with nausea creates choking risk
- Hyperthermia or hypothermia: Impaired thermoregulation at high doses
Emergency response: Place the person in the recovery position. Monitor breathing. Call emergency services if breathing is slow, shallow, or irregular; if the person is unresponsive to stimulation; or if seizures occur. Be honest with medical personnel about what was consumed — they are there to help, not to judge.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration
Tolerance
| Full | Unknown |
| Half | Unknown |
| Zero | Unknown |
Legal Status
The legal status of Inhalants varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of Inhalants in their jurisdiction before any involvement with this substance.
Tips (4)
Have a sitter present when using Inhalants, especially at higher doses. Dissociated individuals may wander, fall, or injure themselves without realizing it. A sober person can prevent physical accidents.
Dissociative aftereffects from Inhalants can include cognitive fog, poor coordination, and impaired judgment for hours after the main experience. Do not drive, make important decisions, or use machinery until fully baseline.
Do not combine Inhalants with other CNS depressants (alcohol, opioids, benzodiazepines). Dissociatives already depress breathing and cardiovascular function. Adding other depressants creates dangerous respiratory depression.
If insufflating Inhalants, start with a small bump and wait 15-20 minutes to assess effects before taking more. Onset via insufflation is faster than oral, but full effects still take time to manifest.
See Also
References (3)
- Ketamine as a rapid antidepressant — Berman et al. Biological Psychiatry (2000)paper
- Inhalants - TripSit Factsheet
TripSit factsheet for Inhalants
tripsit - Inhalants - Wikipedia
Wikipedia article on Inhalants
wikipedia